IRIS PubliCatt

Salerno, Maria Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.482
EU - Europa 1.210
AS - Asia 252
AF - Africa 35
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 2.992
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.473
DE - Germania 481
SE - Svezia 212
CN - Cina 132
UA - Ucraina 106
IT - Italia 97
FR - Francia 70
IE - Irlanda 67
PL - Polonia 49
SG - Singapore 44
GB - Regno Unito 39
IN - India 39
CI - Costa d'Avorio 32
FI - Finlandia 27
RU - Federazione Russa 21
ES - Italia 11
IR - Iran 11
BE - Belgio 8
JP - Giappone 7
HK - Hong Kong 5
MX - Messico 5
TR - Turchia 5
CA - Canada 4
NL - Olanda 4
SI - Slovenia 4
VN - Vietnam 4
BR - Brasile 3
CL - Cile 3
CZ - Repubblica Ceca 3
EG - Egitto 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
EC - Ecuador 2
SA - Arabia Saudita 2
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
CH - Svizzera 1
DK - Danimarca 1
EU - Europa 1
HU - Ungheria 1
KR - Corea 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
Totale 2.992
Salva come PNG Salva come JPEG
Città #
Chandler 397
Ashburn 141
New York 69
Dublin 66
San Mateo 61
Ann Arbor 56
Jacksonville 52
Wilmington 43
Fairfield 38
Nanjing 35
Abidjan 32
Boston 31
Dearborn 30
Nürnberg 30
Kraków 27
Houston 25
Redwood City 23
Singapore 23
Lawrence 20
Milan 20
Princeton 20
Warsaw 20
Rome 19
Woodbridge 19
Moscow 18
Beijing 17
Marseille 13
Los Angeles 12
Seattle 10
Andover 9
Chicago 9
Brussels 8
Leawood 8
Augusta 7
Boardman 7
Cattolica 7
Hangzhou 7
Hebei 7
Nanchang 7
Norwalk 7
Tianjin 7
Zhengzhou 7
Guangzhou 6
Pune 6
University Park 6
Bremen 5
Costa Mesa 5
Fremont 5
Redmond 5
Shenyang 5
Tokyo 5
Bologna 4
Busto Arsizio 4
Changchun 4
Changsha 4
Helsinki 4
Hong Kong 4
Izmir 4
Jiaxing 4
Mexico 4
Romainville 4
San Diego 4
Washington 4
Bangalore 3
Detroit 3
Hanoi 3
Kunming 3
Lancaster 3
Mountain View 3
São Paulo 3
Amsterdam 2
Bolzano 2
Brno 2
Cambridge 2
Dallas 2
Esslingen am Neckar 2
Groningen 2
Guayaquil 2
Haikou 2
Hefei 2
Izola 2
Jinan 2
Kish 2
Kochi 2
Las Vegas 2
Ljubljana 2
Manchester 2
Monmouth Junction 2
Phoenix 2
Porto 2
San Francisco 2
San Jose 2
Saronno 2
Senigallia 2
Toronto 2
Ancona 1
Arcola 1
Ardabil 1
Auckland 1
Austin 1
Totale 1.636
Salva come PNG Salva come JPEG
Nome #
Elderly and very elderly advanced ovarian cancer patients: Does the age influence the surgical management? 231
Effectiveness of the Transoral Endoscopic Vertical Gastroplasty (TOGa®): a good balance between weight loss and complications, if compared with gastric bypass and biliopancreatic diversion 128
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors. 114
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 114
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 112
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 107
Once Daily Everolimus Is Safe and Effective in De Novo Renal Transplant Recipients: Six-Month Results of a Pilot Study. 96
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 93
Complete clinical remission of psoriasis 6 months after renal transplantation 89
The reduction of left ventricular hypertrophy after renal transplantation is not influenced by the immunosuppressive regimen. 89
USE OF A SINGLE DOSE OF BASILIXIMAB AFTER MAJOR SURGICAL PROCEDURES IN KIDNEY TRANSPLANT RECIPIENTS 88
LAPDOCTOR: TELL ME HOW DIFFICULT WILL BE MY DONOR 88
Effectiveness of the Transoral Endoscopic Vertical Gastroplasty (TOGa®): a good balance between weight loss and complications, if compared with gastric bypass and biliopancreatic diversion 87
AN EASY ALGORITHM TO OPTIMIZE THE EXPOSURE TO TACROLIMUS AND EVEROLIMUS, WHEN USED IN COMBINATION 84
Significant improvement in patient survival after renal transplantation in the last decade. 83
Do patients who participate in a clinic experimental protocol have the same probability of success from that who were not selected or refused to participate? Outcome surveillance, safety, and bioethical considerations in kidney transplant clinical research 81
Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up 80
CHYLOUS ASCITES AFTER LAPAROSCOPIC LIVING DONOR NEPHRECTOMY. CASE REPORT AND REVIEW OF THE LITERATURE 74
COMBINATION OF EXTENDED-RELEASE TACROLIMUS PLUS EVEROLIMUS ONCE-DAILY IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: ER-TAC VERSUS LCPT 74
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 71
Posttransplant encapsulating peritoneal sclerosis, long-term success with everolimus and low-dose CNI: a case report 69
Once-a-day administration of everolimus is safe in de novo renal transplant recipients: 1-year results of a pilot study 68
Evolution of causes of mortality in renal transplantation in the last 10 years 67
Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. 64
TO TRANSPLANT OR NOT TO TRANSPLANT: A KIDNEY WITH A GIANT CYST. CASE REPORT AND REVIEW OF THE LITERATURE 64
[Organ transplantation: training and prospects for a young surgeon] 62
How Challenging Will Be My Living Donor? CT Scan and Clinical Evaluation Can Predict Technical Difficulty of Laparoscopic Donor Nephrectomy 61
Combination of Extended-Release Tacrolimus Plus Everolimus Once Daily in Dc Novo Kidney Transplant Recipients: ER-Tac vs LCPT 57
Perioperative-, recipient-, and donor-related factors affecting delayed graft function in kidney transplantation 56
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors 52
Radiofrequency thermal ablation of renal graft neoplasms: A literature review 52
Inferior Long-Term Outcomes for Kidney Transplant Recipients With an Immunologically Mediated Primary Renal Disease 51
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience 51
Thymoglobuline plus basiliximab a mixed cocktail to start? 47
Radiofrequency thermal ablation of renal graft neoplasms: Case series and literature review 45
Incidence of Posttransplant Diabetes Mellitus in Kidney Transplant Recipients Immunosuppressed With Sirolimus in Combination With Cyclosporine 44
Are there any relations among transplant centre volume, surgical technique and anatomy for donor graft selection? Ten-year multicentric Italian experience on mini-invasive living donor nephrectomy 40
Cardiovascular Risk Profile in Kidney Transplant Recipients Treated With Two Immunosuppressive Regimens: Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine 37
Higher Incidence of Acute Rejection in Renal Transplant Recipients With Low Everolimus Exposure 33
Elderly kidney transplant recipient with intermittent fever: A case report of leishmaniasis with acute kidney injury during liposomal amphotericin B therapy 16
Induction With Basiliximab Plus Thymoglobulin Is Effective and Safe in Old-for-Old Renal Transplantation: Six-Month Results of a Prospective Clinical Study 15
Totale 3.034
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.754
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.754
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020251 0 13 21 6 6 22 39 5 24 12 63 40
2020/2021325 32 31 10 27 41 26 39 6 45 10 51 7
2021/2022400 14 31 7 15 17 9 16 69 16 29 74 103
2022/2023962 126 137 66 175 40 116 52 80 122 12 24 12
2023/2024398 23 97 7 44 15 89 17 26 7 10 29 34
2024/202532 21 11 0 0 0 0 0 0 0 0 0 0
Totale 3.034